Linike Medical Group Ltd.
LNMG
$0.0061
$0.00011.67%
OTC PK
| 07/31/2014 | 04/30/2014 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -43.43% | -48.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -43.43% | -48.17% | |||
| Operating Income | 43.43% | 48.17% | |||
| Income Before Tax | 54.39% | 40.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 54.39% | 40.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.39% | 40.31% | |||
| EBIT | 43.43% | 48.17% | |||
| EBITDA | 43.88% | 48.42% | |||
| EPS Basic | 54.55% | 40.00% | |||
| Normalized Basic EPS | 53.66% | 40.58% | |||
| EPS Diluted | 54.55% | 40.00% | |||
| Normalized Diluted EPS | 53.66% | 40.58% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||